- Home
- CRVO vs UG Comparison
CRVO vs UG Comparison
Compare CRVO & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | UG |
|---|---|---|
| Founded | 2001 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 30.8M |
| IPO Year | 2011 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CRVO | UG |
|---|---|---|
| Price | $2.29 | $6.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 61.4K | 3.8K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $4,006,510.00 | ★ $10,545,468.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.79 | $5.58 |
| 52 Week High | $13.13 | $9.88 |
Technical Indicators
Market Signals| Indicator | CRVO | UG |
|---|---|---|
| Relative Strength Index (RSI) | 23.02 | 48.05 |
| Support Level | N/A | $6.86 |
| Resistance Level | $4.27 | $7.70 |
| Average True Range (ATR) | 0.21 | 0.21 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 8.03 | 11.11 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About UG United-Guardian Inc.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.